News

Nadia Rosenthal to take up new US position

25 March 2015
New appointment is in many ways a homecoming for Professor Rosenthal
World-renowned researcher Professor Nadia Rosenthal, founding Director of the Australian Regenerative Medicine Institute (ARMI) at Monash University and joint leader of Stem Cells Australia’s Cardiac Regeneration and Repair research program, has accepted a newly created position as Scientific Director of The Jackson Laboratory (JAX) in Maine.

Professor Rosenthal will join JAX in May and take-up the Directorship by the end of the year. She will also retain an honorary post at Monash University.

The Jackson Laboratory is an independent, non-profit biomedical research institution employs 1600 staff. Its mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health.

The new appointment is in many ways a homecoming for Professor Rosenthal. After gaining her PhD in biochemistry at Harvard Medical School, Professor Rosenthal collaborated with JAX researchers, developing her career-long focus to map the workings of the immune system during the regeneration of heart tissue. Her work has led to developments in innovative cell-based treatments for muscle ageing and heart disease, and she is a global leader in the use of targeted mutagenesis in mice to investigate muscle development, disease and repair.

Since coming to Monash, Professor Rosenthal has made a substantial contribution to the Australian field of regenerative medicine and stem cell science.

As founding Director of the $153 million ARMI – a joint venture between Monash University and the Victorian Government – she established a vibrant new home for regenerative medicine with more than 230 scientists and students exploring key questions about how regeneration occurs in the heart, muscle and the nervous system, as well as the role of stem cells and immunity. She has also been instrumental in gaining membership for Australia as the first country outside Europe to join the European Molecular Biology Laboratory - Europe’s preeminent life science research laboratory and was a founding scientist and co-author of the original bid to secure funding for the Stem Cells Australia initiative.

Commenting on her contribution, Stem Cells Australia’s Program Leader Professor Martin Pera said, “Nadia has been a fantastic member of our Stem Cells Australia team.  She has contributed to all facets of our activities right from the outset, and in particular her strong advocacy and mentoring of young researchers in our group has been invaluable. She has been a great collaborator and colleague and we wish her the best as she takes up this exciting new opportunity in the US. Although her direct involved in our initiative will be greatly missed, we look forward to maintaining our relationship with her, and exploring further collaborative opportunities that will be enabled by her new role.  

On behalf of all of our scientists and administrative staff, I thank Nadia for her invaluable contributions to Stem Cells Australia and Australian science, and wish her the very best in her this exciting new endeavor.”

Professor Rosenthal is a Fellow of the UK Academy of Medical Sciences, an EMBO member, a recipient of the Ferrari-Soave Prize in Cell Biology and was awarded Doctors Honoris Causa from the Universite Pierre et Marie Curie in Paris and the University of Amsterdam. She also holds a Chair in Cardiovascular Science at Imperial College London. She has served on numerous international grant review committees and advisory panels and has coordinated several major EU consortia on mouse genetics and disease models. She is a Founding Editor of Disease Models and Mechanisms and Editor-in-Chief of Differentiation.

Congratulations Nadia!